Evidence map›Paper›PMID 25378398›Full record

ArticleThe Journal of biological chemistry2014

Zymogen activation and subcellular activity of subtilisin kexin isozyme 1/site 1 protease.

Joel Ramos da Palma, Dominique Julien Burri, Joël Oppliger, Marco Salamina, Laura Cendron, Patrizia Polverino de Laureto, Nabil Georges Seidah, Stefan Kunz, Antonella Pasquato

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.9field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 24 citations in OpenAlex.

  1. Review
  2. Structural basis for substrate selectivity by site-one protease revealed by studies with a small-molecule inhibitor.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 3 countries.

Joel Ramos da PalmaFrom the Institute of Microbiology, University Hospital Center and University of Lausanne, 1011 Lausanne, Switzerland.
Dominique Julien BurriFrom the Institute of Microbiology, University Hospital Center and University of Lausanne, 1011 Lausanne, Switzerland.
Joël OppligerFrom the Institute of Microbiology, University Hospital Center and University of Lausanne, 1011 Lausanne, Switzerland.
Marco Salaminathe Department of Biology and.
Laura Cendronthe Department of Biology and.
Patrizia Polverino de Lauretothe Department of Pharmaceutical Sciences, Centro Ricerche Interdipartimentale Biotecnologie Innovative, University of Padua, 35121 Padua, Italy, and.
Nabil Georges Seidahthe Laboratory of Biochemical Neuroendocrinology, Clinical Research Institute of Montreal, University of Montreal, Montreal, Quebec H2W 1R7, Canada.
Stefan KunzFrom the Institute of Microbiology, University Hospital Center and University of Lausanne, 1011 Lausanne, Switzerland, Stefan.Kunz@chuv.ch.
Antonella PasquatoFrom the Institute of Microbiology, University Hospital Center and University of Lausanne, 1011 Lausanne, Switzerland, Antonella.Pasquato@chuv.ch.
University of Lausanne · CHMontreal Clinical Research Institute · CAUniversity of Padua · IT

Funding

Canadian Institutes of Health Research 93792
6 · The paper itself

Abstract

The proprotein convertase subtilisin kexin isozyme 1 (SKI-1)/site 1 protease (S1P) plays crucial roles in cellular homeostatic functions and is hijacked by pathogenic viruses for the processing of their envelope glycoproteins. Zymogen activation of SKI-1/S1P involves sequential autocatalytic processing of its N-terminal prodomain at sites B'/B followed by the herein newly identified C'/C sites. We found that SKI-1/S1P autoprocessing results in intermediates whose catalytic domain remains associated with prodomain fragments of different lengths. In contrast to other zymogen proprotein convertases, all incompletely matured intermediates of SKI-1/S1P showed full catalytic activity toward cellular substrates, whereas optimal cleavage of viral glycoproteins depended on B'/B processing. Incompletely matured forms of SKI-1/S1P further process cellular and viral substrates in distinct subcellular compartments. Using a cell-based sensor for SKI-1/S1P activity, we found that 9 amino acid residues at the cleavage site (P1-P8) and P1' are necessary and sufficient to define the subcellular location of processing and to determine to what extent processing of a substrate depends on SKI-1/S1P maturation. In sum, our study reveals novel and unexpected features of SKI-1/S1P zymogen activation and subcellular specificity of activity toward cellular and pathogen-derived substrates.

Indexed as

Amino Acid SequenceAnimalsCHO CellsCricetulusEnzyme ActivationEnzyme PrecursorsImmunity, InnateMolecular Sequence DataProprotein ConvertasesProtein FoldingProtein Processing, Post-TranslationalProtein Structure, TertiaryProtein TransportProteolysisSerine EndopeptidasesViral Envelope ProteinsEnzyme Precursorsmembrane-bound transcription factor peptidase, site 1Proprotein ConvertasesSerine EndopeptidasesViral Envelope ProteinsBioluminescenceBiosensorEnzyme MechanismEnzyme ProcessingSerine Protease

Identifiers

PMID25378398
PMCPMC4276844
OpenAlexW2040109415

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.